Tecnimede Group
Mohamed Amine Chibane is a seasoned professional in the pharmaceutical industry, currently serving as a Medical Sales Representative in cardiology at Tecnimede Group since March 2021. Prior to this role, Mohamed served as a Pharmaceutical Representative at Pharmaceutical Institute S.A. from January 2019 to March 2021, and as a Visiteur médical at Laboratoires Novopharma from August 2017 to December 2018. Mohamed Amine Chibane has pursued education at ADN FORMATION and Amadeus, enhancing expertise in the field.
This person is not in any offices
Tecnimede Group
1 followers
TECNIMEDE GROUP is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use: development, manufacture, promotion and marketing. TECNIMEDE GROUP's strategy is based on a strong investment in Research, Development and Production of Medicinal Products. It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalization. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. The TECNIMEDE GROUP’s commercial activity is based on: - The solid positioning of the three commercial lines in Portugal; - The direct presence in Spain, Italy, Morocco, Colombia and Brazil; - The establishment of local partnerships in the more than 40 countries where it exports — almost all the European Union countries, as well as several countries in Africa, South America, North America, Asia and the Middle East. TECNIMEDE GROUP's portfolio includes more than 100 products, as a result of its R&D center, which results in more than 2,500 MAs worldwide. Our Mission is the "Improvement and preservation of human life and health through the development, production and marketing of pharmaceutical products with a strong focus on quality and technological innovation.